Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues
- PMID: 7558029
- DOI: 10.1006/geno.1995.1079
Alternative splicing of the tuberous sclerosis 2 (TSC2) gene in human and mouse tissues
Abstract
The recently isolated gene for tuberous sclerosis 2 (TSC2) encodes a 5.5-kb transcript that is widely expressed. The TSC2 gene product, named tuberin, is a 1784-amino-acid protein that shows a small stretch of homology to the GTPase activating protein rap1GAP. We have detected a novel variant of the TSC2 mRNA lacking 129 nucleotides, predicting an in-frame deletion of 43 amino acids spanning codons 946-988 of tuberin. This 129-bp deletion precisely corresponds to exon 25 of the TSC2 gene suggesting that alternative splicing leads to production of two forms of transcripts designated isoforms 1 and 2. Further molecular analysis revealed a third isoform exhibiting a deletion of 44 amino acids spanning codons 946-989 of tuberin. Amino acid 989 is a Ser residue encoded by the first codon of exon 26. The two isoforms also exist in newborn and adult mouse tissues, reinforcing the potential functional importance of these alternatively spliced products. These alternative isoforms should have implications for efforts aimed at identifying mutations in TSC patients. The distinct polypeptides encoded by the TSC2 gene may have different targets as well as functions involved in the regulation of cell growth.
Similar articles
-
Cloning, developmental expression, and evidence for alternative splicing of the murine tuberous sclerosis (TSC2) gene product.Cell Mol Biol Res. 1995;41(6):515-26. Cell Mol Biol Res. 1995. PMID: 8777431
-
Identification of tuberous sclerosis 2 messenger RNA splice variants that are conserved and differentially expressed in rat and human tissues.Cell Growth Differ. 1995 Sep;6(9):1185-91. Cell Growth Differ. 1995. PMID: 8519695
-
Deletion of 11 amino acids in tuberin associated with severe tuberous sclerosis phenotypes: evidence for a new essential domain in the first third of the protein.Eur J Hum Genet. 1997 Sep-Oct;5(5):280-7. Eur J Hum Genet. 1997. PMID: 9412784
-
Mutation screening of the entire coding regions of the TSC1 and the TSC2 gene with the protein truncation test (PTT) identifies frequent splicing defects.Hum Mutat. 1999;14(5):401-11. doi: 10.1002/(SICI)1098-1004(199911)14:5<401::AID-HUMU6>3.0.CO;2-R. Hum Mutat. 1999. PMID: 10533066
-
Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex.Acta Neurol Scand. 2005 Jan;111(1):54-63. doi: 10.1111/j.1600-0404.2004.00366.x. Acta Neurol Scand. 2005. PMID: 15595939
Cited by
-
Report of a critical recombination further narrowing the TSC1 region.J Med Genet. 1996 Jul;33(7):559-61. doi: 10.1136/jmg.33.7.559. J Med Genet. 1996. PMID: 8818940 Free PMC article.
-
Variants Within TSC2 Exons 25 and 31 Are Very Unlikely to Cause Clinically Diagnosable Tuberous Sclerosis.Hum Mutat. 2016 Apr;37(4):364-70. doi: 10.1002/humu.22951. Epub 2016 Jan 12. Hum Mutat. 2016. PMID: 26703369 Free PMC article.
-
Germ-line mutational analysis of the TSC2 gene in 90 tuberous-sclerosis patients.Am J Hum Genet. 1998 Feb;62(2):286-94. doi: 10.1086/301705. Am J Hum Genet. 1998. PMID: 9463313 Free PMC article.
-
Perfect match: mTOR inhibitors and tuberous sclerosis complex.Orphanet J Rare Dis. 2022 Mar 4;17(1):106. doi: 10.1186/s13023-022-02266-0. Orphanet J Rare Dis. 2022. PMID: 35246210 Free PMC article. Review.
-
Rho-associated kinase connects a cell cycle-controlling anchorage signal to the mammalian target of rapamycin pathway.J Biol Chem. 2011 Jul 1;286(26):23132-41. doi: 10.1074/jbc.M110.209114. Epub 2011 May 11. J Biol Chem. 2011. PMID: 21561859 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases